{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:19:13Z","timestamp":1762100353483},"reference-count":14,"publisher":"FapUNIFESP (SciELO)","issue":"3B","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Neuro-Psiquiatr."],"published-print":{"date-parts":[[1998,9]]},"abstract":"<jats:p>Quatorze pacientes foram avaliados no servi\u00e7o de emerg\u00eancia da Santa Casa de S\u00e3o Paulo devido a cefal\u00e9ia aguda. Quatro pacientes tinham o diagn\u00f3stico de enxaqueca com aura e cinco o de enxaqueca sem aura. Quatro pacientes foram diagnosticados como portadores de cefal\u00e9ia cr\u00f4nica di\u00e1ria com interparoxismos de enxaqueca. E finalmente um paciente tinha o diagn\u00f3stico de hemicrania parox\u00edstica cr\u00f4nica. Todos os pacientes receberam diagn\u00f3stico de acordo com os crit\u00e9rios da International Headache Society, para a cefal\u00e9ia que motivou a procura do atendimento de emerg\u00eancia. A dose de clorpromazina usada foi 0,7 mg\/Kg dilu\u00edda em solu\u00e7\u00e3o glicosada a 5% e a dose m\u00e1xima nunca excedeu 50 mg. O tempo de administra\u00e7\u00e3o nunca foi inferior a 60 minutos. Os resultados foram considerados excelentes em todos os casos. Alguns pacientes apresentaram efeitos colaterais, particularmente hipotens\u00e3o ortost\u00e1tica, sempre moderada e transit\u00f3ria. Este estudo demonstra claramente que a clorpromazina (0,7 mg\/Kg) \u00e9 altamente eficaz para tratamento de epis\u00f3dios de cefal\u00e9ia prim\u00e1ria.<\/jats:p>","DOI":"10.1590\/s0004-282x1998000400008","type":"journal-article","created":{"date-parts":[[2005,4,15]],"date-time":"2005-04-15T14:22:47Z","timestamp":1113574967000},"page":"565-568","source":"Crossref","is-referenced-by-count":6,"title":["Uso de clorpromazina para tratamento de cefal\u00e9ia no servi\u00e7o de emerg\u00eancia"],"prefix":"10.1590","volume":"56","author":[{"given":"AGNALDO R. DA","family":"COSTA","sequence":"first","affiliation":[{"name":"Santa Casa de S\u00e3o Paulo,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PAULO H\u00c9LIO","family":"MONZILLO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WILSON LUIZ","family":"SANVITO","sequence":"additional","affiliation":[{"name":"Santa Casa de S\u00e3o Paulo,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","first-page":"1","article-title":"Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pains","volume":"8","year":"1988","journal-title":"Cephalalgia","ISSN":"http:\/\/id.crossref.org\/issn\/0333-1024","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1056\/NEJM199311113292008","article-title":"Drug therapy of migraine","volume":"329","author":"Welsh KMA","year":"1993","journal-title":"N Engl J Med","ISSN":"http:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0165-6147(92)90097-P","article-title":"Neurogenic versus vascular mechanisms of sumatriptam and ergot alkaloids in migraine","volume":"13","author":"Moskowitz MA","year":"1992","journal-title":"Trends Pharmacol Sci","ISSN":"http:\/\/id.crossref.org\/issn\/0165-6147","issn-type":"print"},{"key":"ref4","first-page":"264","article-title":"Apomorphine induced yawning in migraine patients: enhanced responsiveness","volume":"13","author":"Blin O","year":"1990","journal-title":"Clin Neuropharmacol","ISSN":"http:\/\/id.crossref.org\/issn\/0362-5664","issn-type":"print"},{"key":"ref5","first-page":"129","article-title":"Hyperresponsiveness of migraine patients to the hypotensive action of bromocriptine","volume":"17","author":"Fancioullacci M","year":"1980","journal-title":"Headache","ISSN":"http:\/\/id.crossref.org\/issn\/0017-8748","issn-type":"print"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1212\/WNL.49.3.650","article-title":"Dopamine and migraine","volume":"49","author":"Peroutka SJ","year":"1997","journal-title":"Neurology","ISSN":"http:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref7","first-page":"120","article-title":"Chorea and migraine: \"hemicrania choreatetotica\"?","volume":"4","author":"Bruin GW","year":"1984","journal-title":"Chephalalgia"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1212\/WNL.49.1.201","article-title":"Clinical suceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) Ncol alleles","volume":"49","author":"Peroutka SJ","year":"1997","journal-title":"Neurology","ISSN":"http:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0736-4679(94)00121-9","article-title":"A new approach to emergency therapy of migraine headache with intravenous haloperidol: a case series","volume":"13","author":"Ficher H","year":"1995","journal-title":"J Emerg Med","ISSN":"http:\/\/id.crossref.org\/issn\/0736-4679","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0196-0644(05)81508-2","article-title":"A prospective double-blind study of metoclopramide hydrochloride for the control of migraine in the emergency department","volume":"19","author":"Tek DS","year":"1990","journal-title":"Ann Emerg Med","ISSN":"http:\/\/id.crossref.org\/issn\/0196-0644","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1001\/jama.1989.03420080094038","article-title":"Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache","volume":"261","author":"Jones S","year":"1989","journal-title":"JAMA","ISSN":"http:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0196-0644(89)80570-0","article-title":"Comparative efficacy of chlorpromazine and meperidine with dimenhydrinate in migraine headache","volume":"18","author":"Lane DL","year":"1989","journal-title":"Ann Emerg Med","ISSN":"http:\/\/id.crossref.org\/issn\/0196-0644","issn-type":"print"},{"key":"ref13","first-page":"284","article-title":"Parenteral chlorpromazine treatment of migraine","volume":"12","author":"Iserson KV","year":"1982","journal-title":"BMJ","ISSN":"http:\/\/id.crossref.org\/issn\/0959-8138","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1526-4610.1985.hed2506302.x","article-title":"Intravenous chlorpromazine: preliminary results in acute migraine","volume":"25","author":"Lane PL","year":"1985","journal-title":"Headache","ISSN":"http:\/\/id.crossref.org\/issn\/0017-8748","issn-type":"print"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/anp\/v56n3b\/1768.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,24]],"date-time":"2017-05-24T20:06:00Z","timestamp":1495656360000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-282X1998000400008&lng=pt&tlng=pt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,9]]},"references-count":14,"journal-issue":{"issue":"3B","published-print":{"date-parts":[[1998,9]]}},"alternative-id":["S0004-282X1998000400008"],"URL":"https:\/\/doi.org\/10.1590\/s0004-282x1998000400008","relation":{},"ISSN":["0004-282X"],"issn-type":[{"value":"0004-282X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,9]]}}}